Hologic Inc. (HOLX)
70.16
-0.13 (-0.18%)
At close: Jan 14, 2025, 3:59 PM
69.28
-1.25%
Pre-market Jan 15, 2025, 04:08 AM EST
undefined% (undefined)
| Bid | 27.8 |
| Market Cap | 15.92B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 3.32 |
| PE Ratio (ttm) | 21.13 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 69.5 |
| Volume | 1,903,404 |
| Avg. Volume (20D) | 1,983,290 |
| Open | 70.16 |
| Previous Close | 70.29 |
| Day's Range | 69.80 - 70.77 |
| 52-Week Range | 69.46 - 84.67 |
| Beta | undefined |
About HOLX
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima vi...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Mar 1, 1990
Employees 6,990
Stock Exchange NASDAQ
Ticker Symbol HOLX
Website https://www.hologic.com
Analyst Forecast
According to 14 analyst ratings, the average rating for HOLX stock is "Hold." The 12-month stock price forecast is $90, which is an increase of 28.28% from the latest price.
Buy 50.00%
Hold 42.86%
Sell 0.00%
Next Earnings Release
Hologic Inc. is scheduled to release its earnings on Feb 5, 2025,
after market closes.
Analysts project revenue of $1.02B, reflecting a 0.69% YoY growth and earnings per share of 1.01, making a 3.06% increase YoY.
Analysts project revenue of $1.02B, reflecting a 0.69% YoY growth and earnings per share of 1.01, making a 3.06% increase YoY.
2 months ago ·
Source
-5.88%
Hologic shares are trading lower. The company repo...
Unlock content with
Pro Subscription
5 months ago ·
Source
+1.28%
Hologic shares are trading lower after the company issued soft guidance.
